Pancreatic cancer

A multipronged approach to pancreatic cancer treatment

Research has highlighted the importance of the stroma in pancreatic cancer, in particular the role of complex interactions between cancer and stromal cells. A new study describes a novel mechanism by which stromal pathways can be modulated to inhibit tumour growth. The findings support the concept that a multipronged therapeutic approach targeting pancreatic cancer cells and cancer stroma could improve clinical outcomes for this disease.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Apte, M. V. et al. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 29, 179–187 (2004).

    CAS  Article  PubMed  Google Scholar 

  2. 2

    Wörmann, S. M. et al. Loss of P53 function activates JAK2–STAT3 signaling to promote pancreatic tumor growth, stroma modification, and gemcitabine resistance in mice and is associated with patient survival. Gastroenterology (2016).

  3. 3

    Apte, M. V., Pirola, R. C. & Wilson, J. S. in Stellate Cells in Health and Disease 1st edn Vol. 1 (eds Gandhi, C. S. & Pinzani, M.) 271–299 (Elsevier, 2015).

    Google Scholar 

  4. 4

    Wang, L. M. et al. The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma. Oncotarget 7, 4183–4194 (2016).

    PubMed  Google Scholar 

  5. 5

    Pothula, S. P. et al. Key role of pancreatic stellate cells in pancreatic cancer. Cancer Lett. (2015).

  6. 6

    Zhang, H. et al. Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells. Oncotarget 6, 3085–3097 (2015).

    PubMed  Google Scholar 

  7. 7

    Cabrera, M. C. et al. Human pancreatic cancer-associated stellate cells remain activated after in vivo chemoradiation. Front. Oncol. 4, 102 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  8. 8

    Rhim, A. D. et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25, 735–747 (2014).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. 9

    Ozdemir, B. C. et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25, 719–734 (2014).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. 10

    Pothula, S. P. et al. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer. Br. J. Cancer 114, 269–280 (2016).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references


The authors acknowledge the support of grant funding from the National Health and Medical Research Council of Australia and the New South Wales Cancer Council.

Author information



Corresponding author

Correspondence to Minoti V. Apte.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Apte, M., Wilson, J. A multipronged approach to pancreatic cancer treatment. Nat Rev Gastroenterol Hepatol 13, 385–387 (2016).

Download citation

Further reading


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing